¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Central states speech journal."¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • speech articulation
    ¾ð¾î±¸À½
  • speech audiogram
    ¾ð¾îû·Âµµ
  • speech audiometer
    ¾ð¾îû·Â°è
  • speech audiometry
    ¾ð¾îû·Â°Ë»ç
  • speech automatism
    ¸»ÇϱâÀÚµ¿Áõ
  • speech center
    ¾ð¾îÁßÃß
  • speech discrimination
    ¸»¼Ò¸®¸í·áµµ, ¾îÀ½¸í·áµµ
  • speech discrimination score
    ¾îÀ½¸í·áµµ, ¸»¼Ò¸®¸í·áµµ°ª
  • speech disturbance
    ¾ð¾îÀå¾Ö
  • speech hearing
    ¸»¼Ò¸®µè±â, ¾îÀ½Ã»·Â
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç, ¸»¼Ò¸®Ã»·Â¼Õ½Ç
  • speech interference level
    ¾ð¾î¹æÇØÄ¡, ´ëÈ­¹æÇØÄ¡
  • speech pathologist
    ¾ð¾îº´¸®ÇÐÀÚ
  • speech pathology
    ¾ð¾îº´¸®ÇÐ
  • speech range
    ¾ð¾îÁÖÆÄ¿ª, È­¼º¿ª
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • explosive speech
    Æø¹ß¾ð¾î
  • speech hearing
    ¸»¼Ò¸®µè±â, ¾îÀ½Ã»·Â
  • speech hearing loss
    ¾îÀ½Ã»·Â¼Õ½Ç, ¸»¼Ò¸®Ã»·Â¼Õ½Ç
  • incoherent speech
    Áö¸®¸ê·ÄÇѸ»
  • interjectional speech
    °¨Åº¼º¸»
  • jumbled speech
    ³­ÀâÇѸ»
  • speech interference level
    ȸȭ¹æÇØÄ¡
  • nasal speech
    ºñ¼º¾î, ºñÀ½Áõ
  • pressured speech
    ¾ð¾î¾Ð¹Ú
  • propositional speech
    ¸íÁ¦¾ð¾î
  • speech pathologist
    ¾ð¾îº´¸®ÇÐÀÚ
  • reluctant speech
    ¸¶Áö¸øÇØÇϴ¸»
  • speech range
    ¾ð¾îÁÖÆÄ¿ª, È­¼º¿ª
  • speech
    ¾îÀ½, ¾ð¾î, ¸»¼Ò¸®
  • scamping speech
    ÀÚÀ½Å»¶ô¾ð¾î
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • anteromedial central branches
    ¾Õ¾ÈÂÊÁ߽ɰ¡Áö
  • artery of central sulcus
    Á߽ɰí¶ûµ¿¸Æ
  • glial cell of central nervous system
    ÁßÃ߾Ʊ³¼¼Æ÷
  • gray central
    Áß½Éȸ»öÁú(ñéãýüéßäòõ).
  • harversian canal central canal
    Á߽ɰü
  • hearing loss, central
    ÁßÃß¼º û·Â¼Ò½Ç, ÁßÃß¼º ³­Ã»
  • posterolateral central arteries
    µÚ°¡ÂÊÁ߽ɵ¿¸Æ
  • posteromedial central arteries
    µÚ¾ÈÂÊÁ߽ɵ¿¸Æ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • hearing speech clinic
    û°¢¾ð¾îŬ¸®´Ð
  • hearing test, speech
    ¾îÀ½Ã»·Â°Ë»ç
  • hearing, speech
    ¾îÀ½Ã»·Â
  • incoherent speech
    Áö¸®¸ê·ÄÇÑ ¾ð¾î,»ê¶õ(¼º)¾ð¾î
  • inner language =internal speech
    ³»¾ð¾î
  • interjectional speech
    °¨Åº¼º ¾ð¾î
  • jumbled speech
    ³­Àâ¾ð¾î(Õ¯íÚåëåÞ).
  • motor speech area
    ¿îµ¿¾ð¾î·É(¡­åëåÞçÐ).
  • motor speech area
    ¿îµ¿¾ð¾î·É(¡­åëåÞçÐ).
  • motor speech center
    ¿îµ¿¼º ¾ð¾îÁßÃß(¡­àõåëåÞñéõÒ).
  • motor speech production
    ¿îµ¿¼º ¾ð¾î»ê»ý(¡­ß§ßæ).
  • nasal speech
    ºñ¼º¾î, ºñÀ½Áõ
  • optic speech center
    ½Ã°¢(¼º) ¾ð¾îÁßÃß(ãÊÊÆàõåëåÞñéõÒ).
  • pressured speech
    ¾ð¾î¾Ð¹Ú£¨åëåÞäâÚÞ£©
  • propositional speech
    ¸íÁ¦¾ð¾î(Ù¤ð¹åëåÞ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • Central canal
    Á߽ɰü
    [¿¾ ¿ë¾î] Á߽ɰü
  • Harversian canal [Central canal]
    Á߽ɰü
    [¿¾ ¿ë¾î] °ñ¿øÁ߽ɰü
  • Central zone
    Á߽ɱ¸¿ª
    [¿¾ ¿ë¾î] Á߽ɴë
  • Central tendon
    Á߽ɳÎÈûÁÙ
    [¿¾ ¿ë¾î] °ÇÁß½É
  • Central tegmental tract
    Áß½ÉµÚÆÇ·Î
    [¿¾ ¿ë¾î] Áß½ÉÇǰ³·Î
  • Central lacteal
    Á߽ɸ²ÇÁ°ü
    [¿¾ ¿ë¾î] Áß½ÉÀӯİü
  • Central lymph nodes
    Á߽ɸ²ÇÁÀý
    [¿¾ ¿ë¾î] Áß½ÉÀÓÆÄÀý
  • Central heterochromatic part
    Á߽ɹ¶Ä£¿°»öÁúºÎºÐ
    [¿¾ ¿ë¾î] Áß½ÉÀÌ¿°»öÁúºÎ
  • Central microtubule
    Á߽ɹ̼¼°ü
    [¿¾ ¿ë¾î] Á߽ɹ̼Ұü
  • Central part
    Á߽ɺκÐ
    [¿¾ ¿ë¾î] Á߽ɺÎ
  • Central attachment
    Á߽ɺÎÂø
    [¿¾ ¿ë¾î] Á߽ɺÎÂø
  • Central insertion
    Á߽ɺÎÂø
    [¿¾ ¿ë¾î] Á߽ɺÎÂø
  • Central fiber
    Á߽ɼ¶À¯
    [¿¾ ¿ë¾î] Á߽ɼ¶À¯
  • Central lobule
    Á߽ɼҿ±
    [¿¾ ¿ë¾î] ¼Ò³úÁ߽ɼҿ±
  • Ala of central lobule
    Á߽ɼҿ±³¯°³
    [¿¾ ¿ë¾î] Á߽ɼҿ±ÀÍ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
CVO central vein occlusion; central venous oxygen; Chief Veterinary Officer; credentialing verification ...
AJKD American Journal of Kidney Diseases
JOC Journal of Oncologic Clinical(?)
AEM Academic Emergency Medicine [journal]; analytical electron microscopy; ambulatory electrocardiograph...
AM Academic Medicine [journal]; actomyosin; acute myelofibrosis; adult male; adult monocyte; aerospace ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
US EPA United States Environmental Protection Agency
USMLE United States Medical Licensing Examination
USPHS United States Public Health Service
USRDS United States Renal Data System
U.S.A. United States of America
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sound articulation of speech
    ¹ßÀ½ÀÇ ¼Ò¸®
  • speech aid
    ¹ßÀ½ º¸Á¶±â, ¹ßÀ½ º¸ Á¶ÀåÄ¡
    ¾ð¾î ´É·ÂÁúÀ» Çâ»ó½Ã۱â À§ÇØ »ç¿ëÇÏ´Â Ä¡·á ±â±¸, ÀåÄ¡.
  • speech aid prosthesis modification
    ¹ßÀ½ º¸Á¶ º¸Ã¶¹° º¯Çü
  • speech articulation
    ±¸À½
  • speech bulb
    ¹ßÀ½ º¸Á¶ ÀåÄ¡
  • speech difficulty
    ¹ßÀ½ Àå¾Ö, ¾ð¾î Àå¾Ö
    µ¿ÀǾî=s
  • speech disorder
    ¾ð¾î Àå¾Ö
    ¸»À» ¹Ù¸£°Ô ¹ßÀ½ÇÏÁö ¸øÇϰųª Á¤È®ÇÏ°Ô ÀÌÇØÇÏÁö ¸øÇÏ´Â »óÅÂ. Àΰ£Àº ¸»
  • speech hearing test
    ¾îÀ½ û·Â °Ë»ç
  • speech pathologist
    ¾ð¾î º´¸®ÇÐÀÚ
  • speech prosthesis
    ¹ßÀ½ º¸Ã¶¹°
  • speech sound
    ¹ßÀ½, À½¼º
  • speech therspist
    ¾ð¾î ¿ä¹ý»ç
    ȯÀÚÀÇ ¾ð¾î Àå¾Ö ±Øº¹¿¡ Á¶·ÂÀ» ÁÖ°Ô²û Ưº°ÇÑ ÈÆ·ÃÀ» ¹Þ°í, ÀÚ°ÝÀÌ ÀÖ´Â »ç¶÷.
  • staccato speech
    ´Ü¼Ó ¾ð¾î
    ´Ù¹ß¼º °æÈ­Áõ¿¡¼­ º¼ ¼ö ÀÖ´Â, °¢ À½Àý¸¶´Ù ºÐ¸®Çؼ­ ¸»ÇÏ´Â ¾ð¾î.
  • symbolic speech
    »ó¡ ¾ð¾î
  • central
    Áß½ÉÀÇ, Áß¾ÓÀÇ, ÁßÃßÀÇ, ÁßÃß¼ºÀÇ, ÁßÃß¼º, Á߽ɼº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
united states federal trade commission An independent administrative agency concerned with maintaining competitive free enterprise by prohibiting unfair methods of competition and unfair deceptive acts or practices.
(12 Dec 1998)
united states food and drug administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to maintaining standards of quality of foods, drugs, therapeutic devices, etc.
(12 Dec 1998)
united states health care financing administration A component of the department of health and human services to oversee and direct the medicare and medicaid programs and related federal medical care quality control staffs.
(12 Dec 1998)
united states health resources and services administration A component of the public health service that provides leadership related to the delivery of health services and the requirements for and distribution of health resources, including manpower training.
(12 Dec 1998)
united states indian health service A division of the united states public health service that is responsible for the public health and the provision of medical services to native american indian populations in the united states, primarily those residing on reservation lands.
(12 Dec 1998)
united states national aeronautics and space administration An independent federal agency established in 1958. It conducts research for the solution of problems of flight within and outside the earth's atmosphere and develops, constructs, tests, and operates aeronautical and space vehicles.
(12 Dec 1998)
united states occupational safety and health administration An office in the department of labour responsible for developing and establishing occupational safety and health standards.
(12 Dec 1998)
united states office of economic opportunity A division of the executive branch of the united states government concerned with overall planning, promoting, and administering programs relative to the provision of opportunities for economic advancement.
(12 Dec 1998)
united states office of research integrity An office of the united states public health service organised in june 1992 to promote research integrity and investigate misconduct in research supported by the public health service. It consolidates the office of scientific integrity of the national institutes of health and the office of scientific integrity review in the office of the assistant secretary for health. The ori is in the office of the assistant secretary for health and its director reports directly to the assistant secretary for health, department of health and human services. (ri newsletter, 1993 jan; 1(1):1)
(12 Dec 1998)
united states office of technology assessment An office established to help congress participate and plan for the consequences of uses of technology. It provides information on both the beneficial and adverse effects of technological applications.
(12 Dec 1998)
united states public health service See: USPHS.
(12 Dec 1998)
united states social security administration The social security administration administers a national program of contributory social insurance whereby employees, employers, and the self-employed pay contributions that are pooled in special trust funds. When earnings are reduced because of retirement, death, or disability, monthly benefits are paid to partially replace lost earnings. Part of the contributions go into a separate hospital insurance trust fund for workers when they become 65 to provide help with medical expenses. Other programs include the supplemental social security income program for the aged, blind, and disabled and the old age survivors and disability insurance program. Ssa became an independent agency march 31, 1995. It had previously been part of the department of health, education, and welfare, later the department of health and human services.
(12 Dec 1998)
united states substance abuse and mental health services administration An agency of the public health service concerned with the overall planning, promoting, and administering of programs pertaining to substance abuse and mental health. It is commonly referred to by the acronym samhsa. On 1 october 1992, the united states alcohol, drug abuse, and mental health administration (adamha) became samhsa. (telephone communication with samhsa 7 april 1992)
(12 Dec 1998)
alaryngeal speech A form of speech achieved after laryngectomy by using either an external vibratory source or the pharyngoesophageal segment as an internal vibratory source. Tracheoesophageal speech may be produced after laryngectomy by surgically diverting exhaled air to the pharynx by a permanently constructed tracheoesophageal fistula.
(05 Mar 2000)
american speech-language-hearing association A professional society concerned with the diagnosis, prevention, treatment, and remediation of speech, language, and hearing disorders.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • free speech
    ÀÚÀ¯ ¾ð·Ð;¾ð·ÐÀÇ ÀÚÀ¯
  • indirect speech
    (¿µ)INDIRECT DISCOURSE
  • inner speech form
    ³»ºÎ ¾ð¾î Çü½Ä
  • reported speech
    °£Á¢ È­¹ý;ÇÇÀü´ÞºÎ
  • represented speech
    ¹¦ÃâÈ­¹ý(Á÷Á¢È­¹ý°ú °£Á¢È­¹ýÀÇ Áß°£Àû ¼ºÁúÀ» °¡Áø)
  • robot speech
    Àΰø ÇÕ¼º À½¼º(synthetic speech)
  • speech
    ¸»;¾ð¾î ±¹¾î ¹æ¾ð;Ç¥Çö·Â;À̾߱â;´ãÈ­;¸»Åõ;¾ð¾î´É·Â;¿¬¼³;¿¬¼³¹ý;È­¹ý
  • speech clinic
    ¾ð¾îÀå¾Ö ±³Á¤¼Ò
  • speech day
    (Çб³)Á¹¾÷½Ä ³¯
  • speech from
    ¾ð¾îÇü½Ä
  • speech reading
    (º¡¾î¸®ÀÇ)µ¶È­¹ý;µ¶¼ø¼ú
  • speech therapy
    ¾ð¾îÀå¾Ö ±³Á¤(¼ú) 
  • stump speech
    ¼±°Å(Á¤Ä¡)¿¬¼³
  • visible speech
    ½ÃÈ­(¹ý) (À½¼º ±âÈ£ ü°èÀÇ Çϳª)
  • central
    Áß½ÉÀÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á